News & Articles

Comprehensive pharmacogenetic testing solution aligned with latest clinical guidance to support informed chemotherapy treatment decisions

Enhanced pharmacogenetic workflow includes additional variants to support safer, personalised chemotherapy treatment for cancer patients

Three-in-one system integrates large fragment analytics, DNA size selection and fluorometric quantification for long-read sequencing

Offers expectant parents fully comprehensive prenatal screening test for genetic conditions, including microdeletions

The Yourgene Cystic Fibrosis Base assay is a Class C in vitro medical device under IVDR and is intended for use by healthcare professionals within a molecular laboratory environment

The system offers flexibility in blood collection tube choice enabling cost-effective workflows in non-invasive prenatal testing